JP2017501211A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017501211A5 JP2017501211A5 JP2016552481A JP2016552481A JP2017501211A5 JP 2017501211 A5 JP2017501211 A5 JP 2017501211A5 JP 2016552481 A JP2016552481 A JP 2016552481A JP 2016552481 A JP2016552481 A JP 2016552481A JP 2017501211 A5 JP2017501211 A5 JP 2017501211A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- chain variable
- variable region
- antibody
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 11
- 102000004965 antibodies Human genes 0.000 claims 10
- 108090001123 antibodies Proteins 0.000 claims 10
- 102000005614 monoclonal antibodies Human genes 0.000 claims 2
- 108010045030 monoclonal antibodies Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
Claims (8)
- SEQ ID NO:9のアミノ酸配列を有する軽鎖可変領域とSEQ ID NO:10のアミノ酸配列を有する重鎖可変領域とを含む、単離された抗体。
- モノクローナル抗体である、請求項1に記載の抗体。
- その配列が、SEQ ID NO:9のアミノ酸配列を有する軽鎖可変領域とSEQ ID NO:10のアミノ酸配列を有する重鎖可変領域とを含む抗体をコードする、核酸。
- SEQ ID NO:9のアミノ酸配列を有する軽鎖可変領域とSEQ ID NO:10のアミノ酸配列を有する重鎖可変領域とを含む抗体を発現する、抗体発現細胞株。
- SEQ ID NO:11のアミノ酸配列を有する軽鎖可変領域とSEQ ID NO:12のアミノ酸配列を有する重鎖可変領域とを含む、単離された抗体。
- モノクローナル抗体である、請求項5に記載の抗体。
- その配列が、SEQ ID NO:11のアミノ酸配列を有する軽鎖可変領域とSEQ ID NO:12のアミノ酸配列を有する重鎖可変領域とを含む抗体をコードする、核酸。
- SEQ ID NO:11のアミノ酸配列を有する軽鎖可変領域とSEQ ID NO:12のアミノ酸配列を有する重鎖可変領域とを含む抗体を発現する、抗体発現細胞株。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361900942P | 2013-11-06 | 2013-11-06 | |
US61/900,942 | 2013-11-06 | ||
US201462054324P | 2014-09-23 | 2014-09-23 | |
US62/054,324 | 2014-09-23 | ||
US201462064380P | 2014-10-15 | 2014-10-15 | |
US62/064,380 | 2014-10-15 | ||
PCT/US2014/064327 WO2015069880A1 (en) | 2013-11-06 | 2014-11-06 | Assays for igfbp7 having improved performance in biological samples |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019212462A Division JP2020048569A (ja) | 2013-11-06 | 2019-11-25 | 生体試料中で改善された性能を有するigfbp7のためのアッセイ |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017501211A JP2017501211A (ja) | 2017-01-12 |
JP2017501211A5 true JP2017501211A5 (ja) | 2017-11-24 |
Family
ID=53042071
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016552481A Pending JP2017501211A (ja) | 2013-11-06 | 2014-11-06 | 生体試料中で改善された性能を有するigfbp7のためのアッセイ |
JP2019212462A Pending JP2020048569A (ja) | 2013-11-06 | 2019-11-25 | 生体試料中で改善された性能を有するigfbp7のためのアッセイ |
JP2022003920A Active JP7277623B2 (ja) | 2013-11-06 | 2022-01-13 | 生体試料中で改善された性能を有するigfbp7のためのアッセイ |
JP2023000938A Pending JP2023052239A (ja) | 2013-11-06 | 2023-01-06 | 生体試料中で改善された性能を有するigfbp7のためのアッセイ |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019212462A Pending JP2020048569A (ja) | 2013-11-06 | 2019-11-25 | 生体試料中で改善された性能を有するigfbp7のためのアッセイ |
JP2022003920A Active JP7277623B2 (ja) | 2013-11-06 | 2022-01-13 | 生体試料中で改善された性能を有するigfbp7のためのアッセイ |
JP2023000938A Pending JP2023052239A (ja) | 2013-11-06 | 2023-01-06 | 生体試料中で改善された性能を有するigfbp7のためのアッセイ |
Country Status (12)
Country | Link |
---|---|
US (3) | US9822172B2 (ja) |
EP (2) | EP3066221A4 (ja) |
JP (4) | JP2017501211A (ja) |
KR (1) | KR102404285B1 (ja) |
CN (1) | CN105793439B (ja) |
AU (1) | AU2014346695B2 (ja) |
BR (1) | BR112016010106A2 (ja) |
CA (2) | CA2929547C (ja) |
EA (1) | EA201690731A1 (ja) |
HK (1) | HK1221490A1 (ja) |
MX (1) | MX2016005834A (ja) |
WO (1) | WO2015069880A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106370857A (zh) | 2008-10-21 | 2017-02-01 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
CN102725636B (zh) | 2009-12-20 | 2015-04-01 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
NZ605698A (en) | 2010-06-23 | 2015-03-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP3540440B1 (en) | 2011-12-08 | 2022-09-28 | Astute Medical, Inc. | Methods and uses for evaluating renal injury and renal status |
CA3158996A1 (en) | 2013-01-17 | 2014-07-24 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US10300108B2 (en) | 2013-12-03 | 2019-05-28 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US11243202B2 (en) | 2015-04-09 | 2022-02-08 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
ES2774967T3 (es) | 2015-10-08 | 2020-07-23 | Hoffmann La Roche | IGFBP7 para la predicción del riesgo de LRA cuando se mide antes de una intervención quirúrgica |
US11243217B2 (en) | 2016-06-06 | 2022-02-08 | Astute Medical, Inc. | Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 |
CN110431422A (zh) | 2017-02-06 | 2019-11-08 | 机敏医药股份有限公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
JP7315466B2 (ja) | 2017-04-05 | 2023-07-26 | アスチュート メディカル,インコーポレイテッド | 生体試料中において改善した性能を有する、timp2に関するアッセイ |
BR112020023943A2 (pt) | 2018-05-24 | 2021-02-09 | Renibus Therapeutics, Inc. | métodos de tratamento de pacientes em risco de lesão renal e insuficiência renal |
WO2020234482A1 (en) * | 2019-05-21 | 2020-11-26 | Universität Zürich | MAPKi RESISTANCE SIGNATURES |
KR102533791B1 (ko) * | 2022-09-15 | 2023-05-18 | 경북대학교 산학협력단 | 비색법 신호형질 복합체, 이를 이용하는 신장질환 진단용 키트 및 진단법 |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3029579C2 (de) | 1980-08-05 | 1985-12-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut |
US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
US5413923A (en) | 1989-07-25 | 1995-05-09 | Cell Genesys, Inc. | Homologous recombination for universal donor cells and chimeric mammalian hosts |
US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
SG48759A1 (en) | 1990-01-12 | 2002-07-23 | Abgenix Inc | Generation of xenogenic antibodies |
US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
US5166051A (en) | 1990-08-08 | 1992-11-24 | Genesis Labs, Inc. | Membranes, membrane overlays for exclusion of erythrocytes, and method for immunoassay of whole blood analytes |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
EP0546073B1 (en) | 1990-08-29 | 1997-09-10 | GenPharm International, Inc. | production and use of transgenic non-human animals capable of producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
JPH05504841A (ja) | 1990-09-14 | 1993-07-22 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途 |
GB9109645D0 (en) | 1991-05-03 | 1991-06-26 | Celltech Ltd | Recombinant antibodies |
US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
AU1772992A (en) | 1991-04-10 | 1992-11-17 | Biosite Diagnostics Incorporated | Crosstalk inhibitors and their uses |
EP0579767B1 (en) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Novel conjugates and assays for simultaneous detection of multiple ligands |
US6407213B1 (en) | 1991-06-14 | 2002-06-18 | Genentech, Inc. | Method for making humanized antibodies |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
EP1978033A3 (en) | 1995-04-27 | 2008-12-24 | Amgen Fremont Inc. | Human antibodies derived from immunized xenomice |
CA2219486A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
US6391265B1 (en) | 1996-08-26 | 2002-05-21 | Biosite Diagnostics, Inc. | Devices incorporating filters for filtering fluid samples |
US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
ES2301183T3 (es) | 1996-12-03 | 2008-06-16 | Amgen Fremont Inc. | Anticuerpo completamente humano que se une al receptor del egfr. |
US6045899A (en) | 1996-12-12 | 2000-04-04 | Usf Filtration & Separations Group, Inc. | Highly assymetric, hydrophilic, microfiltration membranes having large pore diameters |
US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
US7109030B2 (en) * | 2000-03-31 | 2006-09-19 | Nuvelo, Inc. | Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides |
US20020132983A1 (en) | 2000-11-30 | 2002-09-19 | Junghans Richard P. | Antibodies as chimeric effector cell receptors against tumor antigens |
US20060263907A1 (en) * | 2005-04-29 | 2006-11-23 | Zweig Stephen E | Fluorescence lateral flow immunoassay |
RS53058B (en) | 2005-07-08 | 2014-04-30 | Biogen Idec Ma Inc. | SP35 ANTIBODIES AND THEIR APPLICATIONS |
CA2671298C (en) * | 2007-01-25 | 2020-07-28 | F. Hoffmann-La Roche Ag | Use of igfbp-7 in the assessment of heart failure |
EP2340262B1 (en) * | 2008-10-14 | 2017-04-05 | National Research Council Canada | Formulations targeting igfbp7 for diagnosis and therapy of cancer |
CN102458459A (zh) | 2009-05-01 | 2012-05-16 | 雅培制药有限公司 | 双重可变结构域免疫球蛋白及其用途 |
CN102725636B (zh) | 2009-12-20 | 2015-04-01 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
CN105158481A (zh) * | 2010-02-05 | 2015-12-16 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
SG10201506782XA (en) * | 2010-08-27 | 2015-10-29 | Stem Centrx Inc | Notum protein modulators and methods of use |
WO2013067517A2 (en) * | 2011-11-03 | 2013-05-10 | Tolera Therapeutics.Inc | Antibody and methods for selective inhibition of t-cell responses |
-
2014
- 2014-11-06 MX MX2016005834A patent/MX2016005834A/es active IP Right Grant
- 2014-11-06 CA CA2929547A patent/CA2929547C/en active Active
- 2014-11-06 AU AU2014346695A patent/AU2014346695B2/en active Active
- 2014-11-06 JP JP2016552481A patent/JP2017501211A/ja active Pending
- 2014-11-06 EA EA201690731A patent/EA201690731A1/ru unknown
- 2014-11-06 BR BR112016010106A patent/BR112016010106A2/pt not_active Application Discontinuation
- 2014-11-06 WO PCT/US2014/064327 patent/WO2015069880A1/en active Application Filing
- 2014-11-06 US US15/035,205 patent/US9822172B2/en active Active
- 2014-11-06 EP EP14860878.9A patent/EP3066221A4/en not_active Withdrawn
- 2014-11-06 CN CN201480066318.8A patent/CN105793439B/zh active Active
- 2014-11-06 KR KR1020167014700A patent/KR102404285B1/ko active IP Right Grant
- 2014-11-06 EP EP19158290.7A patent/EP3556863A1/en active Pending
- 2014-11-06 CA CA3185700A patent/CA3185700A1/en active Pending
-
2016
- 2016-08-11 HK HK16109610.3A patent/HK1221490A1/zh unknown
-
2017
- 2017-11-20 US US15/818,669 patent/US10562961B2/en active Active
-
2019
- 2019-11-25 JP JP2019212462A patent/JP2020048569A/ja active Pending
-
2020
- 2020-01-17 US US16/745,781 patent/US20200247879A1/en not_active Abandoned
-
2022
- 2022-01-13 JP JP2022003920A patent/JP7277623B2/ja active Active
-
2023
- 2023-01-06 JP JP2023000938A patent/JP2023052239A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017501211A5 (ja) | ||
JP2014132019A5 (ja) | ||
JP2014012688A5 (ja) | ||
JP2018100276A5 (ja) | ||
SG11202007074PA (en) | Anti-claudin 18.2 antibodies and uses thereof | |
EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
JP2015133993A5 (ja) | ||
EA202092435A3 (ru) | Моноклональные антитела против bcma | |
JP2018504907A5 (ja) | ||
JP2016028081A5 (ja) | ||
JP2017523796A5 (ja) | ||
EA201991431A1 (ru) | УСИЛЕННЫЙ ОПОСРЕДОВАННЫЙ ТРАНСПОЗОНАМИ СЕМЕЙСТВА hAT ПЕРЕНОС ГЕНОВ И АССОЦИИРОВАННЫЕ КОМПОЗИЦИИ, СИСТЕМЫ И СПОСОБЫ | |
ES2721309T3 (es) | Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa | |
JP2015038108A5 (ja) | ||
JP2016540360A5 (ja) | 基板処理システム及び基板処理方法 | |
DK3331553T3 (da) | Hidtil ukendte, antihumane gpvi-antistoffer og anvendelser deraf | |
IL262747A (en) | Anti-kv1.3 antibodies, methods for their production and use | |
DK3911354T3 (da) | AVV-formidlet genterapi, der genskaber otoferlin-genet | |
EA201691702A1 (ru) | Химерные белки мти | |
IL281198A (en) | New antibodies and sequences and their uses | |
NZ731491A (en) | Cd83 binding proteins and uses thereof | |
JP2017528459A5 (ja) | ||
JP2016047837A5 (ja) | ||
SG11202102531WA (en) | Programming protein polymerization with dna | |
JP2017157543A5 (ja) |